Changes and prognostic value of serum vascular endothelial growth factor in patients with differentiated thyroid cancer

Medical Principles and Practice

Volumn 22, Issue 1, 2012, Pages 24-28

  Zhou, Zhen Hu ^a   Cui, Xiao Ning ^a   Xing, Huai Guang ^a   Yan, Rui Hong ^a   Yao, Dao Kuo ^b   Wang, Le Xin ^a,c  

^a TAISHAN MEDICAL UNIVERSITY   (China)

^b CAPITAL MEDICAL UNIVERSITY   (China)

^c CHARLES STURT UNIVERSITY   (Australia)

Author keywords

Cancer; Metastasis; Thyroglobulin; Thyroid; Vascular endothelial growth factor

Indexed keywords

IODINE 131; THYROGLOBULIN; THYROXINE; VASCULOTROPIN;

ADOLESCENT; ADULT; AGED; ARTICLE; CANCER PROGNOSIS; CANCER RECURRENCE; CONTROLLED STUDY; DIFFERENTIATED THYROID CANCER; FEMALE; HORMONE SUBSTITUTION; HUMAN; HUMAN TISSUE; LUNG METASTASIS; MAJOR CLINICAL STUDY; MALE; PATIENT COMPLIANCE; POSTOPERATIVE PERIOD; PREDICTIVE VALUE; PROTEIN BLOOD LEVEL; PROTEIN EXPRESSION; RECURRENCE RISK; THYROGLOBULIN BLOOD LEVEL; THYROID FOLLICULAR CARCINOMA; THYROID PAPILLARY CARCINOMA; TREATMENT REFUSAL;

ADOLESCENT; ADULT; AGE FACTORS; AGED; FEMALE; HUMANS; LUNG NEOPLASMS; MALE; MEDICATION ADHERENCE; MIDDLE AGED; NEOPLASM RECURRENCE, LOCAL; PROGNOSIS; RISK FACTORS; SEX FACTORS; THYROGLOBULIN; THYROID NEOPLASMS; THYROXINE; VASCULAR ENDOTHELIAL GROWTH FACTOR A; YOUNG ADULT;

EID: 84871712184     PISSN: 10117571     EISSN: 14230151     Source Type: Journal    
DOI: 10.1159/000340051     Document Type: Article

References (22)

1. Milano A, Chiofalo MG, Basile M, Salzano de Luna A, Pezzullo L, Caponigro F: New molecular targeted therapies in thyroid cancer. Anticancer Drugs 2006; 17: 869-879. (Pubitemid 44350606)
2. Dhar DK, Kubota H, Kotoh T, Tabara H, Watanabe R, Tachibana M, Kohno H, Nagasue N: Tumor vascularity predicts recurrence in differentiated thyroid carcinoma. Am J Surg 1998; 176: 442-447. (Pubitemid 29021544)
3. Segal K, Shpitzer T, Feinmesser M, Stern Y, Feinmesser R: Angiogenesis in follicular tumors of the thyroid. J Surg Oncol 1996; 63: 95-98. (Pubitemid 26357915)
4. Ishiwata I, Sudo T, Kiguchi K, Ishikawa H: Tumor angiogenesis factors produced by cancer cells. Hum Cell 1999; 12: 37-46.
5. Hsueh C, Lin JD, Wu IC, Chao TC, Yu JS, Liou MJ, Yeh CJ: Vascular endothelial growth factors and angiopoietins in presentations and prognosis of papillary thyroid carcinoma. J Surg Oncol 2011; 103: 395-399.
6. Viglietto G, Maglione D, Rambaldi M, Cerutti J, Romano A, Trapasso F, Fedele M, Ippolito P, Chiappetta G, Botti G, et al: Upregulation of vascular endothelial growth factor (VEGF) and downregulation of placenta growth factor (PLGF) associated with malignancy in human thyroid tumors and cell lines. Oncogene 1995; 11: 1569-1579.
7. Tuttle RM, Fleisher M, Francis GL, Robbins RJ: Serum vascular endothelial growth factor levels are elevated in metastatic differentiated thyroid cancer but not increased by short-term TSH stimulation. J Clin Endocrinol Metab 2002; 87: 1737-1742. (Pubitemid 34615263)
8. Soh EY, Duh QY, Sobhi SA, Young DM, Epstein HD, Wong MG, Garcia YK, Min YD, Grossman RF, Siperstein AE, Clark OH: Vascular endothelial growth factor expression is higher in differentiated thyroid cancer than in normal or benign thyroid. J Clin Endocrinol Metab 1997; 82: 3741-3747. (Pubitemid 27509365)
9. Sherman SI, Wirth LJ, Droz JP, Hofmann M, Bastholt L, Martins RG, Licitra L, Eschenberg MJ, Sun YN, Juan T, Stepan DE, Schlumberger MJ: Motesanib diphosphate in progressive differentiated thyroid cancer. N Engl J Med 2008; 359: 31-42. (Pubitemid 351931094)
10. Yu XM, Lo CY, Chan WF, Lam KY, Leung P, Luk JM: Increased expression of vascular endothelial growth factor C in papillary thyroid carcinoma correlates with cervical lymph node metastases. Clin Cancer Res 2005; 11: 8063-8069. (Pubitemid 41698749)
11. Klubo-Gwiezdzinska J, Junik R, Kopczynska E, Juraniec O, Kardymowicz H: The comparison of serum vascular endothelial growth factor levels between patients with metastatic and non-metastatic thyroid cancer, and patients with nontoxic multinodular goiter. Eur J Endocrinol 2007; 157: 521-527. (Pubitemid 350018457)
12. Karaca Z, Tanriverdi F, Unluhizarci K, Ozturk F, Gokahmetoglu S, Elbuken G, Cakir I, Bayram F, Kelestimur F: VEGF1 expression is related to lymph node metastasis and serum VEGF may be a marker of progression in the follow-up of patients with differentiated thyroid carcinoma. Eur J Endocrinol 2011; 164: 277-284.
13. Yu XM, Lo CY, Lam AK, Leung P, Luk JM: Serum vascular endothelial growth factor C correlates with lymph node metastases and high-risk tumor profiles in papillary thyroid carcinoma. Ann Surg 2008; 247: 483-489.
14. Nersita R, Matrone A, Klain M, Scavuzzo F, Vitolo G, Abbondanza C, Carlino MV, Giacco V, Amato G, Carella C: Decreased serum vascular endothelial growth factor-D levels in metastatic patients with differentiated thyroid carcinoma. Clin Endocrinol (Oxf) 2012; 76: 142-146.
15. Spencer CA, LoPresti JS, Fatemi S, Nicoloff JT: Detection of residual and recurrent differentiated thyroid carcinoma by serum thyroglobulin measurement. Thyroid 1999; 9: 435-441. (Pubitemid 29244919)
16. Karayiannakis AJ, Syrigos KN, Polychronidis A, Zbar A, Kouraklis G, Simopoulos C, Karatzas G: Circulating VEGF levels in the serum of gastric cancer patients: Correlation with pathological variables, patient survival, and tumor surgery. Ann Surg 2002; 236: 37-42. (Pubitemid 34686448)
17. Mitsuhashi A, Suzuka K, Yamazawa K, Matsui H, Seki K, Sekiya S: Serum vascular endothelial growth factor (VEGF) and VEGFC levels as tumor markers in patients with cervical carcinoma. Cancer 2005; 103: 724-730. (Pubitemid 40216400)
18. Tamura M, Ohta Y: Serum vascular endothelial growth factor-C level in patients with primary nonsmall cell lung carcinoma: A possible diagnostic tool for lymph node metastasis. Cancer 2003; 98: 1217-1222. (Pubitemid 37099906)
19. Katoh R, Miyagi E, Kawaoi A, Hemmi A, Komiyama A, Oyama T, Shibuya M: Expression of vascular endothelial growth factor (VEGF) in human thyroid neoplasms. Hum Pathol 1999; 30: 891-897. (Pubitemid 29380511)
20. Viglietto G, Romano A, Manzo G, Chiappetta G, Paoletti I, Califano D, Galati MG, Mauriello V, Bruni P, Lago CT, Fusco A, Persico MG: Upregulation of the angiogenic factors PlGF, VEGF and their receptors (Flt-1, Flk-1/KDR) by TSH in cultured thyrocytes and in the thyroid gland of thiouracil-fed rats suggest a TSH-dependent paracrine mechanism for goiter hypervascularization. Oncogene 1997; 15: 2687-2698. (Pubitemid 27507616)
21. Itoh A, Iwase K, Jimbo S, Yamamoto H, Yamamoto N, Kokubo M, Senda T, Nakai A, Nagagasaka A, Nagasaka T, Hibi Y, Seko T: Expression of vascular endothelial growth factor and presence of angiovascular cells in tissues from different thyroid disorders. World J Surg 2010; 34: 242-248.
22. Sherman SI: Targeted therapies for thyroid tumors. Mod Pathol 2011; 24(suppl 2):S44-S52.